Tomer Langberg is an R&D Scientist advancing molecular therapeutics, drug delivery systems, and neurotechnology. Tomer completed a PhD in Molecular & Cell Biology at UC-Berkeley, where research led to a significant paradigm shift in therapeutic targeting for autism. They have authored seven high-impact publications, including five in Nature and Cell-family journals, accumulating over 600 citations. Currently, Tomer serves as a Senior R&D Researcher at Mapi Pharma, focusing on formulations for long-acting injectables. Tomer has also been a Fulbright postdoctoral fellow at Tel Aviv University, where they engaged in research on Alzheimer's Disease and taught graduate-level courses in neuroscience.
This person is not in the org chart
This person is not in any teams
This person is not in any offices